Track the HAWKINS INC share price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Chemicals & Materials sector, HAWKINS INC has logged 122 reports. Market capitalisation: €2.8bn. The latest transaction was disclosed on 15 May 2026 (Attribution). Among the most active insiders: Hawkins Patrick H.. Every trade is free.
Analysts rate HAWKINS INC Buy (bullish), based on 4 analysts. Average price target: US$184.50.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
25 of 122 declarations
Hawkins, Inc. (ticker HWKN) is a U.S.-listed company quoted on Nasdaq in the United States. It operates in the specialty chemicals and water treatment space, with a business model centered on formulation, manufacturing, distribution, and blending of value-added products. Founded in 1938, Hawkins has evolved from a chemical distributor into a diversified industrial solutions provider. The company is headquartered in Roseville, Minnesota, which remains its operational anchor while supporting a broad national footprint. Hawkins’ reporting structure is built around three core segments: Water Treatment, Food & Health Sciences, and Industrial Solutions. Water Treatment is the company’s most strategically important platform and serves municipal and industrial customers with chemicals, equipment, and technical services. This segment has expanded through targeted tuck-in acquisitions and has become a major driver of growth. In 2025, Hawkins completed the acquisition of WaterSurplus, a transaction that meaningfully broadened the company’s water-treatment capabilities, including membrane systems, engineering and design services, filtration media, equipment rental and manufacturing, and rapid-response PFAS-related solutions. Food & Health Sciences focuses on ingredients used in nutrition, dietary supplements, excipients, botanicals, sweeteners, enzymes, and other health-oriented applications. Industrial Solutions provides chemical products and application support for manufacturing and process industries. From a competitive standpoint, Hawkins positions itself as a service-intensive, technically oriented supplier rather than a commodity-only distributor. Management has emphasized customer support, customized applications, and local execution. The competitive landscape is fragmented: the company has stated that no single competitor dominates all of the markets it serves, although many rivals are larger and may have greater financial resources. Hawkins’ nationwide network of facilities across the United States strengthens its logistics, technical service, and customer proximity, which is particularly important in regulated end markets such as water treatment. Recent developments underscore a clear growth narrative. Hawkins reported record fiscal 2025 revenue of $974.4 million and indicated that revenue is expected to surpass $1 billion in fiscal 2026, a symbolic milestone for a company founded 86 years ago. The company has also remained active on the acquisition front, including WaterSurplus, StillWaters Technology, and Redbird Chemical, reinforcing its presence in the southern United States and deepening its higher-margin offering mix. For French-speaking investors, HWKN stands out as a niche industrial compounder with exposure to water infrastructure, specialty ingredients, and a disciplined acquisition strategy. The combination of steady end-market demand, technical differentiation, and ongoing M&A integration is central to the investment case.